Form4insider filings, from the source

SEC Form 4/A · accession 0001209191-17-049506

Dova Pharmaceuticals Inc. · DOVA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Period of report
Jul 5, 2017
Accepted (ET)
Aug 17, 2017 · 6:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001685071

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jul 5, 2017P5,000$19.64A5,000IBy LLC

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

This Amendment to Form 4 filed with the Securities and Exchange Commission on July 7, 2017 is being filed to report the indirect acquisition by the Reporting Person of the shares being reported herein through the Steven M. Goldman Family LLC.